Related Experiment Video
Updated: Aug 16, 2026

Transurethral Induction of Mouse Urinary Tract Infection
Published on: August 5, 2010
Urinary PGE(2) concentrations measured by a new EIA method in infants with urinary tract infections or renal
L Cuzzolin1, P Mangiarotti, V Fanos
1Department of Medicine & Public Health--Section of Pharmacology, University of Verona, Policlinico Borgo Roma, 37134 Verona, Italy. lcuzzolin@univr.it
Insights
Urinary prostaglandin E2 (PGE2) levels are higher in infants with recurrent urinary tract infections (UTIs) or kidney malformations. This non-invasive urine test may aid in diagnosing obstructive uropathies and monitoring kidney function.
Area of Science:
- Pediatric Nephrology
- Biochemistry
Background:
- Recurrent urinary tract infections (UTIs) and renal malformations are significant health concerns in infants.
- Accurate diagnosis and monitoring of renal function are crucial for managing these conditions.
Purpose of the Study:
- To investigate urinary prostaglandin E2 (PGE2) concentrations in infants with recurrent UTIs or renal malformations.
- To evaluate the potential of urinary PGE2 as a non-invasive biomarker for differential diagnosis and renal function monitoring.
Main Methods:
- A novel enzyme immunoassay (EIA) method was used to measure PGE2 concentrations in urine samples.
- Urine samples were collected from infants with recurrent UTIs, renal malformations, and healthy controls.
Main Results:
- Urinary PGE2 excretion rates were significantly higher in infants with recurrent UTIs and renal malformations compared to healthy controls.
- Subjects with obstructive uropathies exhibited particularly elevated PGE2 levels (29.55+/-8.12 pg/ml) compared to non-obstructive cases (18.37+/-4.64 pg/ml).
- No significant correlations were found between PGE2 excretion and age, urine pH, or other renal function indices.
Conclusions:
- Urinary PGE2 is a potential non-invasive biomarker for differentiating obstructive from non-obstructive renal dilatation in infants.
- Measuring urinary PGE2 may assist in monitoring renal function in infants experiencing recurrent UTIs.
Abstract:
In this work PGE(2)concentrations were measured by a new EIA method in the urine of infants (mean age: 9.35+/-4.24 months) with recurrent urinary tract infections or renal malformations. Compared to healthy subjects, PGE(2)excretion rates resulted significantly higher in both pathological groups, in particular in subjects with obstructive uropathies (29.55+/-8.12 vs 18.37+/-4.64 pg/ml). We did not find any age- or pH-dependent difference in urinary excretion of PGE(2); none of the examined indices of renal function showed any significant relationship to PGE(2). These results suggest that this parameter, measured non-invasively in the urine, could help in the differential diagnosis between obstructive vs non-obstructive dilatation and in monitoring renal function in presence of recurrent UTI episodes.
More Related Videos
13:35A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
Published on: March 1, 2018
08:53Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Urine Studies II: Urine Culture and Sensitivity Test